Facebook
Twitter
Telegram
Report an ErrorAkers Biosciences, Inc. Financial Statements 2011-2024 | AKER
Annual Financial Statements Akers Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
809 K | 888 K | 6.36 M | 1.2 M | 3.26 M | 3.08 M | 8 M | 4.14 M | - | - |
Shares |
306 K | 306 K | 229 K | 24.7 K | 14.1 K | 13.4 K | 12.4 K | 4.16 K | - | - |
Net Income |
-17.6 M | -3.89 M | -10.8 M | -5.81 M | -3.3 M | -9.31 M | -3.13 M | -1.53 M | -2.45 M | -3.58 M |
Revenue |
- | 1.58 M | 1.67 M | 3.93 M | 2.96 M | 2.12 M | 4.43 M | 3.58 M | 1.52 M | 1.79 M |
EBITDA |
-12.3 M | -3.76 M | -8.38 M | -4.88 M | -4.46 M | -6.82 M | -2.95 M | -1.55 M | -2.19 M | -3.33 M |
Operating Expenses |
7.99 M | 4.28 M | 8.68 M | 7.56 M | 6.51 M | 8.22 M | 6.46 M | 3.47 M | 3.17 M | 4.74 M |
General and Administrative Expenses |
- | 3.73 M | 5.67 M | 4.08 M | 3.01 M | 4.03 M | 3.98 M | 1.52 M | 1.49 M | 3.28 M |
All numbers in USD currency